APO Research
Talk to an analyst

APO RESEARCH · REPORT

Airsickness Treatment Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Airsickness Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchAirsickness Treatment Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Airsickness Treatment Drug Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Airsickness Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Airsickness Treatment Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Airsickness Treatment Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Airsickness Treatment Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Airsickness Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Airsickness Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Airsickness Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Airsickness Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Airsickness Treatment Drug include Sandoz, Mylan, Pfizer, GlaxoSmithKline, Baxter International, WellSpring Pharmaceutical Corporation, Prestige Brands, Myungmoon Pharm and Caleb Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Airsickness Treatment Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Airsickness Treatment Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Airsickness Treatment Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Airsickness Treatment Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Airsickness Treatment Drug Segment by Company

Sandoz

Mylan

Pfizer

GlaxoSmithKline

Baxter International

WellSpring Pharmaceutical Corporation

Prestige Brands

Myungmoon Pharm

Caleb Pharmaceuticals

Airsickness Treatment Drug Segment by Type

Anticholinergic

Antihistamines

Airsickness Treatment Drug Segment by Application

Adults

Children

Airsickness Treatment Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Airsickness Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Airsickness Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Airsickness Treatment Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Airsickness Treatment Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Airsickness Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Airsickness Treatment Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Airsickness Treatment Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Airsickness Treatment Drug Industry Trends Table 2. Airsickness Treatment Drug Industry Drivers Table 3. Airsickness Treatment Drug Industry Opportunities and Challenges Table 4. Airsickness Treatment Drug Industry Restraints Table 5. Global Airsickness Treatment Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Airsickness Treatment Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Airsickness Treatment Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Airsickness Treatment Drug Sales Market Share by Manufacturers Table 9. Global Airsickness Treatment Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Airsickness Treatment Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Airsickness Treatment Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Airsickness Treatment Drug Manufacturers, Product Type & Application Table 13. Global Airsickness Treatment Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Airsickness Treatment Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anticholinergic Table 17. Major Manufacturers of Antihistamines Table 18. Global Airsickness Treatment Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Airsickness Treatment Drug Sales by Type (2021-2026) & (k units) Table 20. Global Airsickness Treatment Drug Sales by Type (2027-2032) & (k units) Table 21. Global Airsickness Treatment Drug Sales Market Share by Type (2021-2026) Table 22. Global Airsickness Treatment Drug Sales Market Share by Type (2027-2032) Table 23. Global Airsickness Treatment Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Airsickness Treatment Drug Revenue by Type (2021-2026) & (k units) Table 25. Global Airsickness Treatment Drug Revenue by Type (2027-2032) & (k units) Table 26. Global Airsickness Treatment Drug Revenue Market Share by Type (2021-2026) Table 27. Global Airsickness Treatment Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adults Table 29. Major Manufacturers of Children Table 30. Global Airsickness Treatment Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Airsickness Treatment Drug Sales by Application (2021-2026) & (k units) Table 32. Global Airsickness Treatment Drug Sales by Application (2027-2032) & (k units) Table 33. Global Airsickness Treatment Drug Sales Market Share by Application (2021-2026) Table 34. Global Airsickness Treatment Drug Sales Market Share by Application (2027-2032) Table 35. Global Airsickness Treatment Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Airsickness Treatment Drug Revenue by Application (2021-2026) & (k units) Table 37. Global Airsickness Treatment Drug Revenue by Application (2027-2032) & (k units) Table 38. Global Airsickness Treatment Drug Revenue Market Share by Application (2021-2026) Table 39. Global Airsickness Treatment Drug Revenue Market Share by Application (2027-2032) Table 40. Global Airsickness Treatment Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Airsickness Treatment Drug Sales by Region (2021-2026) & (k units) Table 42. Global Airsickness Treatment Drug Sales Market Share by Region (2021-2026) Table 43. Global Airsickness Treatment Drug Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Airsickness Treatment Drug Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Airsickness Treatment Drug Sales by Country (2021-2026) & (k units) Table 47. North America Airsickness Treatment Drug Sales by Country (2027-2032) & (k units) Table 48. Europe Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Airsickness Treatment Drug Sales by Country (2021-2026) & (k units) Table 50. Europe Airsickness Treatment Drug Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Airsickness Treatment Drug Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Airsickness Treatment Drug Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Airsickness Treatment Drug Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Airsickness Treatment Drug Sales by Country (2027-2032) & (k units) Table 57. Global Airsickness Treatment Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Airsickness Treatment Drug Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Airsickness Treatment Drug Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Airsickness Treatment Drug Revenue Market Share by Region (2021-2026) Table 61. Global Airsickness Treatment Drug Revenue Market Share by Region (2027-2032) Table 62. Sandoz Company Information Table 63. Sandoz Business Overview Table 64. Sandoz Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sandoz Airsickness Treatment Drug Product Portfolio Table 66. Sandoz Recent Development Table 67. Mylan Company Information Table 68. Mylan Business Overview Table 69. Mylan Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Mylan Airsickness Treatment Drug Product Portfolio Table 71. Mylan Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer Airsickness Treatment Drug Product Portfolio Table 76. Pfizer Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Airsickness Treatment Drug Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Baxter International Company Information Table 83. Baxter International Business Overview Table 84. Baxter International Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Baxter International Airsickness Treatment Drug Product Portfolio Table 86. Baxter International Recent Development Table 87. WellSpring Pharmaceutical Corporation Company Information Table 88. WellSpring Pharmaceutical Corporation Business Overview Table 89. WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Product Portfolio Table 91. WellSpring Pharmaceutical Corporation Recent Development Table 92. Prestige Brands Company Information Table 93. Prestige Brands Business Overview Table 94. Prestige Brands Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Prestige Brands Airsickness Treatment Drug Product Portfolio Table 96. Prestige Brands Recent Development Table 97. Myungmoon Pharm Company Information Table 98. Myungmoon Pharm Business Overview Table 99. Myungmoon Pharm Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Myungmoon Pharm Airsickness Treatment Drug Product Portfolio Table 101. Myungmoon Pharm Recent Development Table 102. Caleb Pharmaceuticals Company Information Table 103. Caleb Pharmaceuticals Business Overview Table 104. Caleb Pharmaceuticals Airsickness Treatment Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Caleb Pharmaceuticals Airsickness Treatment Drug Product Portfolio Table 106. Caleb Pharmaceuticals Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Airsickness Treatment Drug Distributors List Table 110. Airsickness Treatment Drug Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Airsickness Treatment Drug Product Image Figure 2. Global Airsickness Treatment Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Airsickness Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Airsickness Treatment Drug Sales (2021-2032) & (k units) Figure 5. Global Airsickness Treatment Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Airsickness Treatment Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anticholinergic Image Figure 9. Antihistamines Image Figure 10. Global Airsickness Treatment Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Airsickness Treatment Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Airsickness Treatment Drug Sales Market Share by Type (2021-2032) Figure 13. Global Airsickness Treatment Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Airsickness Treatment Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Airsickness Treatment Drug Revenue Market Share by Type (2021-2032) Figure 16. Adults Image Figure 17. Children Image Figure 18. Global Airsickness Treatment Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Airsickness Treatment Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Airsickness Treatment Drug Sales Market Share by Application (2021-2032) Figure 21. Global Airsickness Treatment Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Airsickness Treatment Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Airsickness Treatment Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Airsickness Treatment Drug Sales Market Share by Country (2021-2032) Figure 26. U.S. Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Airsickness Treatment Drug Sales Market Share by Country (2021-2032) Figure 31. Germany Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Airsickness Treatment Drug Sales Market Share by Country (2021-2032) Figure 38. China Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Airsickness Treatment Drug Sales Market Share by Country (2021-2032) Figure 46. Brazil Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Airsickness Treatment Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Airsickness Treatment Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Airsickness Treatment Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Airsickness Treatment Drug Revenue (2021-2032) & (US$ Million) Figure 57. North America Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Airsickness Treatment Drug Revenue (2021-2032) & (US$ Million) Figure 59. Europe Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Airsickness Treatment Drug Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Airsickness Treatment Drug Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Airsickness Treatment Drug Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Airsickness Treatment Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Anticholinergic
  • Antihistamines
Applications
  • Adults
  • Children
Companies covered
  • Sandoz
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • Baxter International
  • WellSpring Pharmaceutical Corporation
  • Prestige Brands
  • Myungmoon Pharm
  • Caleb Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Airsickness Treatment Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Airsickness Treatment Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Airsickness Treatment Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Airsickness Treatment Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Airsickness Treatment Drug Market Dynamics
  1. 2.1 Airsickness Treatment Drug Industry Trends
  2. 2.2 Airsickness Treatment Drug Industry Drivers
  3. 2.3 Airsickness Treatment Drug Industry Opportunities and Challenges
  4. 2.4 Airsickness Treatment Drug Industry Restraints
3 Airsickness Treatment Drug Market by Manufacturers
  1. 3.1 Global Airsickness Treatment Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Airsickness Treatment Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Airsickness Treatment Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Airsickness Treatment Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Airsickness Treatment Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Airsickness Treatment Drug Manufacturers, Product Type & Application
  7. 3.7 Global Airsickness Treatment Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Airsickness Treatment Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Airsickness Treatment Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Airsickness Treatment Drug Tier 1, Tier 2, and Tier 3
4 Airsickness Treatment Drug Market by Type
  1. 4.1 Airsickness Treatment Drug Type Introduction
  2. 4.1.1 Anticholinergic
  3. 4.1.2 Antihistamines
  4. 4.2 Global Airsickness Treatment Drug Sales by Type
  5. 4.2.1 Global Airsickness Treatment Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Airsickness Treatment Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Airsickness Treatment Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Airsickness Treatment Drug Revenue by Type
  9. 4.3.1 Global Airsickness Treatment Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Airsickness Treatment Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Airsickness Treatment Drug Revenue Market Share by Type (2021-2032)
5 Airsickness Treatment Drug Market by Application
  1. 5.1 Airsickness Treatment Drug Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Airsickness Treatment Drug Sales by Application
  5. 5.2.1 Global Airsickness Treatment Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Airsickness Treatment Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Airsickness Treatment Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Airsickness Treatment Drug Revenue by Application
  9. 5.3.1 Global Airsickness Treatment Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Airsickness Treatment Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Airsickness Treatment Drug Revenue Market Share by Application (2021-2032)
6 Global Airsickness Treatment Drug Sales by Region
  1. 6.1 Global Airsickness Treatment Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Airsickness Treatment Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Airsickness Treatment Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Airsickness Treatment Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Airsickness Treatment Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Airsickness Treatment Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Airsickness Treatment Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Airsickness Treatment Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Airsickness Treatment Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Airsickness Treatment Drug Revenue by Region
  1. 7.1 Global Airsickness Treatment Drug Revenue by Region
  2. 7.1.1 Global Airsickness Treatment Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Airsickness Treatment Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Airsickness Treatment Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Airsickness Treatment Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Airsickness Treatment Drug Revenue (2021-2032)
  8. 7.2.2 North America Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Airsickness Treatment Drug Revenue (2021-2032)
  11. 7.3.2 Europe Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Airsickness Treatment Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Airsickness Treatment Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Airsickness Treatment Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sandoz
  2. 8.1.1 Sandoz Company Information
  3. 8.1.2 Sandoz Business Overview
  4. 8.1.3 Sandoz Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sandoz Airsickness Treatment Drug Product Portfolio
  6. 8.1.5 Sandoz Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Airsickness Treatment Drug Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Airsickness Treatment Drug Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Airsickness Treatment Drug Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Baxter International
  26. 8.5.1 Baxter International Company Information
  27. 8.5.2 Baxter International Business Overview
  28. 8.5.3 Baxter International Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International Airsickness Treatment Drug Product Portfolio
  30. 8.5.5 Baxter International Recent Developments
  31. 8.6 WellSpring Pharmaceutical Corporation
  32. 8.6.1 WellSpring Pharmaceutical Corporation Company Information
  33. 8.6.2 WellSpring Pharmaceutical Corporation Business Overview
  34. 8.6.3 WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 WellSpring Pharmaceutical Corporation Airsickness Treatment Drug Product Portfolio
  36. 8.6.5 WellSpring Pharmaceutical Corporation Recent Developments
  37. 8.7 Prestige Brands
  38. 8.7.1 Prestige Brands Company Information
  39. 8.7.2 Prestige Brands Business Overview
  40. 8.7.3 Prestige Brands Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Prestige Brands Airsickness Treatment Drug Product Portfolio
  42. 8.7.5 Prestige Brands Recent Developments
  43. 8.8 Myungmoon Pharm
  44. 8.8.1 Myungmoon Pharm Company Information
  45. 8.8.2 Myungmoon Pharm Business Overview
  46. 8.8.3 Myungmoon Pharm Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Myungmoon Pharm Airsickness Treatment Drug Product Portfolio
  48. 8.8.5 Myungmoon Pharm Recent Developments
  49. 8.9 Caleb Pharmaceuticals
  50. 8.9.1 Caleb Pharmaceuticals Company Information
  51. 8.9.2 Caleb Pharmaceuticals Business Overview
  52. 8.9.3 Caleb Pharmaceuticals Airsickness Treatment Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Caleb Pharmaceuticals Airsickness Treatment Drug Product Portfolio
  54. 8.9.5 Caleb Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Airsickness Treatment Drug Value Chain Analysis
  2. 9.1.1 Airsickness Treatment Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Airsickness Treatment Drug Production Mode & Process
  6. 9.2 Airsickness Treatment Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Airsickness Treatment Drug Distributors
  9. 9.2.3 Airsickness Treatment Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst